Extension Study Confirms Benefit of Early, Continuous Ocrelizumab in Primary Progressive MS

(MedPage Today) — Study Authors: Jerry S. Wolinsky, Douglas L. Arnold, et al.; Deja R. Rose, Jeffrey A. Cohen
Target Audience and Goal Statement: Neurologists
The goal of this study was to assess the effects of maintaining or switching to ocrelizumab…
Read More